Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

RewinD-LB - Clinical Study of Neflamapimod in Patients With Dementia With Lewy Bodies

ClinicalTrials.gov ID: NCT05869669

Public ClinicalTrials.gov record NCT05869669. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 23, 2026, 4:59 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2b Clinical Study of the P38 Alpha Kinase Inhibitor Neflamapimod in Patients With Dementia With Lewy Bodies

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to determine whether neflamapimod can improve learning skills, problem solving skills, and memory loss in people diagnosed with DLB. More specifically, improvement in verbal learning, memory, and attention, as well as cognitive and functional performance will be measured.

Study identification

NCT ID
NCT05869669
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
EIP Pharma Inc
Industry
Enrollment
159 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
55 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 1, 2023 (Actual)
Primary completion
May 29, 2025 (Actual)
Completion
Jun 16, 2025 (Actual)
Last update posted
Sep 3, 2026

2023 – 2025

United States locations

U.S. sites
29
U.S. states
18
U.S. cities
29
Facility City State ZIP Site status
Barrow Neurological Institute Phoenix Arizona 85013 —
Banner Sun Health Research Institute Sun City Arizona 85351 —
Banner Alzheimer's Institute - Edson Family Lewy Body Dementia Center Tucson Arizona 85718 —
UCSD Health Sciences - Movement Disorders Center La Jolla California 92037 —
Hoag Memorial Hospital Presbyterian Newport Beach California 92663 —
Stanford Neuroscience Health Center Palo Alto California 94304 —
SC3 Research Group Pasadena California 91105 —
University of Colorado - Dept of Neurology Aurora Colorado 80045 —
Georgetown Univ Hospital - Dept of Neurology Washington D.C. District of Columbia 20007 —
JEM Research Institute Lake Worth Florida 33462 —
ClinCloud Melbourne Florida 32940 —
AdventHealth Neuroscience Research Orlando Florida 32804 —
Panhandle Research and Medical Clinic Pensacola Florida 32503 —
University of Kansas Medical Center Kansas City Kansas 66160 —
Tandem Clinical Research Marrero Louisiana 70072 —
Johns Hopkins School of Medicine - Dept of Neurology Baltimore Maryland 21287 —
Mass General Hospital/Harvard Medical School - Dept of Neurology Charlestown Massachusetts 02129 —
Mayo Clinic - Alzheimer's Disease Research Center Rochester Minnesota 55905 —
University of Nebraska Medical Center - Dept of Neurological Sciences Omaha Nebraska 68198 —
Cleveland Clinic - Lou Ruvo Center for Brain Health Las Vegas Nevada 89106 —
Columbia University - Taub Institute/Neurology Dept New York New York 10032 —
University of North Carolina - Dept of Neurology Chapel Hill North Carolina 27599 —
NeuroScience Research Center Canton Ohio 44718 —
Cleveland Clinic - Center for Brain Health Cleveland Ohio 44195 —
Ohio State University - Dept of Neurology Columbus Ohio 43221 —
Center for Cognitive Health Portland Oregon 97225 —
Houston Methodist Hospital - Stanley Appel Neurology Dept Houston Texas 77030 —
Sana Research Arlington Virginia 22205 —
Virginia Commonwealth University - Parkinson's and Movement Disorders Center Richmond Virginia 23298 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 11 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05869669, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 3, 2026 · Synced Oct 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT05869669 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →